William R. Jacobs
- Novel biomarker more strongly associated with tuberculosis treatment outcome than conventional or genotypic methodsBy Allison Wolf, Max O'Donnell, Paras Jain, Vanisha Munsamy, Farina Karim, Michelle Larsen, Alexander Pym and William R. JacobsAllison Wolf1Division of Pulmonary, Allergy & Critical Care Medicine, Columbia University, New York, NY United StatesMax O'Donnell1Division of Pulmonary, Allergy & Critical Care Medicine, Columbia University, New York, NY United StatesParas Jain2Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY United StatesVanisha Munsamy3TB and HIV Research, KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South AfricaFarina Karim3TB and HIV Research, KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South AfricaMichelle Larsen2Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY United StatesAlexander Pym3TB and HIV Research, KwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South AfricaWilliam R. Jacobs2Microbiology & Immunology, Albert Einstein College of Medicine, Bronx, NY United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.